Nilofer Azad, MD
SKCCC Johns Hopkins Medical Institution · Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Medical Institution · SKCCC at the Johns Hopkins Medical Institution
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
14
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
9
PubMed author-name match
Trials
Studies that name Nilofer Azad, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:00 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06411691 · KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · recruiting · Colorectal Cancer, Pancreatic Cancer · principal investigator
- Ph1NCT05013216 · Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · active not recruiting · High Risk Cancer, Pancreatic Cancer · principal investigator
- Ph1NCT04799431 · Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · withdrawn · Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic · principal investigator
- Ph1NCT04117087 · Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · active not recruiting · Colorectal Cancer, Pancreatic Cancer · principal investigator
- Ph2NCT04116073 · INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic · principal investigator
- Ph1NCT03875287 · Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid TumorsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · active not recruiting · Solid Tumor · principal investigator
- Ph1/Ph2NCT03711058 · Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor, Microsatellite Stable (MSS) Colon Cancer · principal investigator
- Ph1NCT03471286 · A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor MalignanciesSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Solid Tumor · principal investigator
- Ph2NCT03250273 · A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic AdenocarcinomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Metastatic Cholangiocarcinoma, Cholangiocarcinoma, Pancreatic Cancer · principal investigator
- Ph2NCT02981524 · Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Metastatic Colorectal Cancer · principal investigator
- Ph1NCT02512172 · A Study of Enhancing Response to MK-3475 in Advanced Colorectal CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Colorectal Cancer · principal investigator
- Ph1NCT01966289 · SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Metastatic Colorectal Cancer · principal investigator
- Ph2NCT01845805 · Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Pancreatic Cancer · principal investigator
- Ph1NCT01537744 · A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and LiposarcomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Solid Tumors, Virally Mediated Cancers and Liposarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Optimization of an active mutant KRAS peptide vaccine in colorectal cancerR01CA296410 · NCI · JOHNS HOPKINS UNIVERSITY · PI Nilofer S. Azad, Neeha Zaidi · fiscal years 2025 to 2026Named on NCT06411691
- Administrative CoreP50CA062924 · NCI · JOHNS HOPKINS UNIVERSITY · PI Alison P Klein · fiscal years 1993 to 2022Named on NCT04799431, NCT04116073
- Integration of neo-antigen vaccines and immune checkpoint therapyP01CA247886 · NCI · JOHNS HOPKINS UNIVERSITY · PI ELIZABETH M. JAFFEE · fiscal years 2021 to 2025Named on NCT04117087, NCT03250273
- Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic CancerK08CA248624 · NCI · JOHNS HOPKINS UNIVERSITY · PI Neeha Zaidi · fiscal years 2021 to 2025Named on NCT04117087
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:00 UTC. The ranking covers the 200 most relevant of 9 PubMed records, and a shared surname and initials can bring in a namesake. All 9 on PubMed
- Maternal Dietary Diversity Decreases with Household Food Insecurity in Rural Bangladesh: A Longitudinal Analysis.J Nutr · 201672 citationsRCR 4.3
- Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.JCI Insight · 202030 citationsRCR 1.3
- Validation of the food access survey tool to assess household food insecurity in rural Bangladesh.BMC Public Health · 201520 citationsRCR 1.0
- Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone and Injection Naltrexone.J Clin Psychiatry · 202216 citationsRCR 1.7
- Posttraumatic Distress Symptoms and Their Response to Treatment in Adults With Prolonged Grief Disorder.J Clin Psychiatry · 202111 citationsRCR 1.1
- 9 citationsRCR 5.0
- 4 citationsRCR 0.3